Compumedics Limited (CMP) Stock Statistics & Valuation Metrics

Compumedics Limited has a market cap or net worth of AU$49.94M. The enterprise value is AU$78.31.

Compumedics Limited has 199,761,750 shares outstanding. The number of shares has decreased by -2.65% in one year.

Compumedics Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.59%.

The current PE Ratio of Compumedics Limited is 227.3. Compumedics Limited’s PEG ratio is -2.23.

In the last 12 months, Compumedics Limited had revenue of 60.25M and earned 214.00K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 6.61M and capital expenditures -181.00K, giving a free cash flow of 6.42M billion.

Compumedics Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Compumedics Limited upcoming earnings date is Mar 4, 2027, TBA (Confirmed).

Compumedics Limited as a current ratio of 1.23, with Debt / Equity ratio of 62.14%

In the past 12 months, Compumedics Limited has paid 1.45M in taxes.

Compumedics Limited EV to EBITDA ratio is 15.69, with an EV/FCF ratio of 9.73.

Compumedics Limited has AU$6.15M in cash and marketable securities with AU$14.11M in debt, giving a net cash position of -AU$7.96M billion.

Gross margin is 51.41%, with operating margin of 2.97%, and net profit margin of 0.36%.

The average price target for Compumedics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―